Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
18.3M
-
Shares change
-
+2.98M
-
Total reported value, excl. options
-
$284M
-
Value change
-
+$45.7M
-
Put/Call ratio
-
0.45
-
Number of buys
-
53
-
Number of sells
-
-26
-
Price
-
$15.48
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q1 2015
92 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q1 2015.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.3M shares
of 157M outstanding shares and own 11.64% of the company stock.
Largest 10 shareholders include FMR LLC (3.06M shares), BRIDGER MANAGEMENT, LLC (2.05M shares), BAKER BROS. ADVISORS LP (2.05M shares), STATE STREET CORP (1.67M shares), Visium Asset Management, LP (1.3M shares), VANGUARD GROUP INC (1.07M shares), BlackRock Fund Advisors (810K shares), BlackRock Institutional Trust Company, N.A. (734K shares), COLUMBUS CIRCLE INVESTORS (461K shares), and Sectoral Asset Management Inc (436K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.